Instalab

Total T3 Test Blood

See whether your body is actually making and converting enough active thyroid hormone, beyond what a basic TSH screen can tell you.

Should you take a Total T3 test?

This test is most useful if any of these apply to you.

Taking Thyroid Medication but Still Symptomatic
See whether your body is converting enough T4 into the active T3 form your cells actually use.
Living with Heart Failure
Low T3 predicts worse outcomes even when TSH looks normal. Track this alongside your cardiac care.
Recovering from a Serious Illness
Find out if illness has suppressed your active thyroid hormone, which can slow your recovery.
Wanting the Full Thyroid Picture
Go beyond TSH screening to see how well your body produces and converts the hormone driving your metabolism.

About Total T3

Your thyroid makes two main hormones: T4, which is mostly a storage form, and T3, which is the version your cells actually use. Most of the T3 circulating in your blood was not released directly by your thyroid. Instead, your liver, kidneys, and other organs convert T4 into T3 as your body needs it. Total T3 measures this entire pool of active hormone: both the fraction bound to carrier proteins and the tiny sliver that is free and available to enter your cells.

This matters because a normal TSH (thyroid stimulating hormone) does not guarantee your T3 is where it should be. Some people convert T4 to T3 efficiently; others do not. Illness, medications, genetics, and even how much protein your liver is making all influence Total T3 independently of what TSH says about your thyroid gland itself. If you want to know whether your body is actually producing and delivering enough active thyroid hormone, Total T3 fills in a piece that TSH and Free T4 alone can miss.

What Total T3 Tells You

Total T3 (total triiodothyronine) is the sum of T3 bound to carrier proteins in your blood, mainly a transport protein called thyroxine-binding globulin (TBG), plus the small free fraction. T3 binds to receptors inside the control center of your cells and switches genes on or off that control how fast you burn calories, how your heart beats, how quickly you think, and how your body grows and repairs itself.

Your thyroid gland sits in the front of your neck and operates under instructions from a feedback loop: a brain region called the hypothalamus releases TRH (thyrotropin-releasing hormone), which tells the pituitary gland to release TSH, which tells the thyroid to produce T4 and a smaller amount of T3. About 70 to 80% of the T3 in your blood was created outside the thyroid by specialized enzymes called deiodinases, which strip an iodine atom off T4 to create the active T3 form. A different enzyme (type 3 deiodinase) can instead convert T4 into reverse T3, an inactive form. The balance between these conversion pathways determines how much active T3 you actually have available.

Because Total T3 reflects both thyroid gland output and peripheral conversion, it captures information about your whole body's thyroid economy, not just whether the gland itself is working. That is both its strength and its complexity: many things besides the thyroid gland itself can move your Total T3 number.

Heart Failure and Critical Illness

When your body is under severe stress from heart failure, a widespread bloodstream infection (sepsis), or other serious illness, one of the first hormonal changes is a drop in T3. This pattern, sometimes called "low T3 syndrome" or non-thyroidal illness, happens because illness shifts your conversion enzymes away from making active T3 and toward making the inactive reverse T3 instead. Your TSH and T4 may look normal, which is why the low T3 can be invisible on a basic thyroid screen.

In a study of 1,365 adults with existing heart failure followed for a median of 4.2 years, those with isolated low T3 (meaning their TSH and T4 were still in the normal range) were about twice as likely to die, need a heart-assist device, or require a transplant compared to those with normal T3 levels (about 2.1 times the risk after adjusting for age, sex, and heart failure severity). Many heart failure and ICU studies have measured Free T3 rather than Total T3, but both decline together in non-thyroidal illness, so the prognostic pattern applies directionally to Total T3 as well. In critically ill patients with sepsis, low T3 levels have been independently associated with 28-day mortality, outperforming some standard intensive care unit scoring systems.

If you have heart failure or are recovering from a serious illness and your Total T3 is low while your TSH looks reassuring, that combination itself carries prognostic weight. It does not necessarily mean you need thyroid hormone treatment, since guidelines do not currently recommend treating low T3 syndrome with thyroid hormone in most cases, but it does mean the underlying illness deserves aggressive attention.

Breast Cancer Risk

A less expected finding links higher prediagnostic T3 levels to breast cancer risk, particularly in postmenopausal women. In the Malmö Preventive Project, a Swedish population study of 2,696 women followed for an average of 19.3 years, women in the highest quarter of Total T3 levels had about 1.9 times the risk of developing breast cancer compared to the lowest quarter. The association was dramatically stronger in postmenopausal women: those in the top quarter had about 6.9 times the risk compared to the bottom quarter, with a clear dose-response trend across all four groups.

A follow-up analysis of 2,185 women from the same cohort, followed for 23.3 years, found that higher prediagnostic T3 was also linked to more aggressive cancers. Women in the top third of T3 levels were about 3.2 times as likely to develop tumors larger than 20 mm, about 4.5 times as likely to have cancer that had spread to lymph nodes, and about 3.5 times as likely to have estrogen-receptor-negative tumors compared to those in the bottom third.

This does not mean that high-normal T3 causes breast cancer. But it does suggest that T3 levels well within the reference range may carry meaningful information about long-term breast cancer risk, especially after menopause. If you are postmenopausal and your Total T3 consistently sits at the upper end of the range, that pattern is worth discussing with your physician alongside other breast cancer risk factors.

Cardiovascular Disease in the General Population

Given the heart failure data, you might expect high or low T3 to also predict heart attacks and strokes in healthy people. The evidence says otherwise. In the Atherosclerosis Risk in Communities (ARIC) study, which followed 11,359 adults for a median of 22.5 years, baseline T3 levels were not significantly associated with incident heart attack or stroke after adjusting for blood pressure, cholesterol, diabetes, and BMI. The risk estimate for a doubling of T3 was about 1.06 for heart attack and 1.10 for stroke, neither statistically significant.

This means Total T3 is valuable for understanding prognosis when you already have heart failure or critical illness, but it does not appear to predict first-time cardiovascular events in an otherwise healthy population. Standard cardiovascular risk markers like lipids, blood pressure, and blood sugar remain the primary tools for that purpose.

Pregnancy Outcomes

Thyroid hormone levels shift substantially during pregnancy. Rising estrogen increases the production of TBG, the main carrier protein for T3 and T4, pushing Total T3 up by roughly 50% above non-pregnant levels by mid-pregnancy. Beyond this expected increase, an individual participant data meta-analysis of over 16,000 pregnancies with Total T3 data found that each standard-deviation increase in gestational Total T3 was associated with a 20% higher odds of gestational hypertension (high blood pressure during pregnancy). Conversely, lower gestational Total T3 was associated with a 28% lower odds of very preterm birth, and higher Total T3 was associated with modestly higher birth weight (about 13 grams per standard deviation increase).

These associations are modest and do not currently support routine Total T3 screening in pregnancy. But if you are pregnant and your thyroid labs include Total T3, these population-level patterns provide context for interpretation. Trimester-specific reference ranges (roughly 1.5 times the non-pregnant upper limit) are needed to avoid misclassifying a normal pregnancy-related T3 rise as hyperthyroidism (overactive thyroid).

Reference Ranges

Total T3 reference ranges vary by laboratory, assay platform, age, and sex. T3 levels decline with age, and women tend to have slightly different distributions than men. Ethnicity can also shift the normal distribution enough that some researchers have called for population-specific reference intervals. The ranges below come from the Cardiovascular Health Study using a Roche Elecsys chemiluminescent immunoassay in U.S. adults aged 65 and older. Your lab may report slightly different numbers, and younger adults generally have values toward the higher end of the range.

TierRange (ng/dL)What It Suggests
LowBelow 85May indicate hypothyroidism, non-thyroidal illness (low T3 syndrome), or low binding protein states. Interpret alongside TSH and Free T4.
Normal85 to 201Reference range in older adults. Younger adults may have values in the upper portion of this range.
ElevatedAbove 201May indicate hyperthyroidism (especially T3-predominant overactive thyroid), high binding protein states (pregnancy, estrogen therapy), or assay interference. Always confirm with TSH.

Compare your results within the same lab over time for the most meaningful trend. A single reading at the edge of the range is far less informative than a pattern across two or three measurements.

When Results Can Be Misleading

Total T3 is one of the more easily confounded thyroid markers, and several common situations can produce a number that does not reflect your true thyroid status.

  • Binding protein changes: Anything that raises TBG will raise Total T3 without changing how much active hormone your cells actually see. Pregnancy and estrogen therapy (including oral contraceptives) are the most common causes, pushing Total T3 up by roughly 50%. Conversely, androgens, severe liver disease, and kidney disease with heavy protein loss lower TBG and can make Total T3 look falsely low. In these situations, Free T3 or Free T4 gives a more accurate picture.
  • Non-thyroidal illness: Acute or chronic illness can drop Total T3 by 30% or more within 24 to 48 hours by shifting your conversion enzymes toward inactive reverse T3. If you have been sick, hospitalized, or recovering from surgery in the days before your blood draw, your Total T3 may be artificially low and should be repeated once you have recovered.
  • Medications that affect T4-to-T3 conversion: High-dose glucocorticoids (such as prednisone) and non-selective beta-blockers (such as propranolol) inhibit the enzymes that convert T4 to T3 and can lower your Total T3 without causing actual thyroid disease. Large iodine loads from contrast dye or amiodarone can transiently suppress T3 and T4 production. If you are taking any of these, mention it when reviewing your results.
  • Assay interference: Biotin supplements, heterophilic antibodies (immune proteins that cross-react with the test), and thyroid hormone autoantibodies can produce falsely high or falsely low results on immunoassay-based thyroid tests. More than half of documented interference cases in thyroid testing led to clinically harmful decisions. If your Total T3 does not match your symptoms, ask your lab to re-run the test using an alternative method.

Tracking Your Trend

A single Total T3 reading is a snapshot taken on one particular morning, influenced by everything from how well you slept to whether you were fighting off a cold. Longitudinal data show that each person has a relatively narrow individual set point for Total T3, roughly half as wide as the population reference range. This means a shift that looks "still normal" on the lab report could actually represent a meaningful change for you, one that the population range is too broad to catch.

If you are tracking Total T3 to understand your thyroid health, get a baseline when you feel well and have not been ill recently. If you are making changes to thyroid medication, supplements, or lifestyle, retest in 6 to 8 weeks to allow the system to reach a new steady state. After that, annual testing is reasonable for most people, with more frequent checks (every 3 to 6 months) if you are adjusting treatment or monitoring a known thyroid condition.

Always use the same lab and the same assay platform for serial comparisons. Different labs can produce meaningfully different numbers for the same blood sample, so switching labs mid-trend makes it hard to tell whether a change is real or just an artifact of the measurement method.

What To Do With an Abnormal Result

Total T3 should never be interpreted alone. It is one piece of a three-part picture that includes TSH and Free T4.

  • Low Total T3 with elevated TSH: This pattern points toward primary hypothyroidism (underactive thyroid). The most common cause is Hashimoto's thyroiditis, an autoimmune condition where antibodies attack the thyroid gland. Order anti-TPO (thyroid peroxidase antibodies) if you have not already, and consider seeing an endocrinologist for treatment with levothyroxine.
  • Low Total T3 with normal TSH and normal or low-normal Free T4: This is the classic pattern of non-thyroidal illness or low T3 syndrome. If you were recently ill, retest in 4 to 6 weeks after recovery. If you were well at the time of the draw, look for binding protein changes (medications, liver disease, kidney disease) and consider checking Free T3 for a clearer picture.
  • High Total T3 with suppressed TSH: This combination suggests hyperthyroidism (overactive thyroid). If Free T4 is still normal, you may have early or T3-predominant thyrotoxicosis, a condition where the thyroid overproduces T3 specifically. This is most commonly caused by Graves' disease or a toxic thyroid nodule. TSH receptor antibodies (TRAb) and a thyroid ultrasound are the next steps, ideally with an endocrinologist.
  • High Total T3 with normal TSH: Before assuming a problem, rule out binding protein elevation from pregnancy, estrogen therapy, or a genetic TBG excess. Check Free T3 or Free T4 to see whether the biologically active fraction is actually elevated.

What Moves This Biomarker

Evidence-backed interventions that affect your Total T3 level

Increase
Switch from levothyroxine alone to combination levothyroxine plus liothyronine (synthetic T3), or to desiccated thyroid extract
Adding synthetic T3 (liothyronine) to T4 therapy, or using desiccated thyroid extract (which contains both T4 and T3), raises your Total T3 by roughly 30 to 50% compared with levothyroxine alone, while lowering the T4/T3 ratio by 38 to 56%. TSH stays in the target range. The most symptomatic third of patients on levothyroxine monotherapy showed improvement in symptoms and cognitive measures when switched to T3-containing regimens.
MedicationStrong Evidence
Increase
Take levothyroxine (synthetic T4) for hypothyroidism
Levothyroxine is the standard treatment for hypothyroidism. Your body converts the supplemental T4 into T3 through its own conversion enzymes. In thyroidectomized patients, levothyroxine alone maintained Total T3 levels at pre-surgery values when TSH was kept in the normal range. However, the T4-to-T3 ratio tends to run higher on levothyroxine alone than it does in people with an intact thyroid, meaning some patients have a T3 level at the low end of normal despite a perfectly normal TSH.
MedicationModerate Evidence
Decrease
Take tyrosine kinase inhibitors (e.g., sunitinib)
Tyrosine kinase inhibitors (TKIs), a class of cancer drugs, reduce thyroid hormone production and alter deiodinase activity, lowering both Free T3 and Free T4 while raising TSH. In a cohort of 34 patients on TKIs, Free T3 and Free T4 fell while TSH increased, consistent with genuine drug-induced thyroid dysfunction that would also lower Total T3. If you are on a TKI, regular thyroid monitoring including T3 is warranted.
MedicationModerate Evidence

Frequently Asked Questions

References

28 studies
  1. Sterenborg RBTM, Steinbrenner I, Li Y, Bujnis M, Naito T, Marouli E, Galesloot T, Babajide O, Andreasen L, Medici MNature Communications2024
  2. Derakhshan a, Männistö T, Chen L, Osinga J, Ashoor G, Lu X, Bliddal S, Korevaar TThe Journal of Clinical Endocrinology and Metabolism2023
  3. Kannan L, Shaw P, Morley M, Brandimarto J, Fang J, Sweitzer N, Cappola T, Cappola aCirculation: Heart Failure2018
  4. Castagna MG, Dentice M, Cantara S, Ambrosio R, Maino F, Porcelli T, Marzocchi C, Garbi C, Pacini F, Salvatore DThe Journal of Clinical Endocrinology & Metabolism2017
  5. Abdelouahab N, Langlois MF, Lavoie L, Corbin F, Pasquier J, Takser LAmerican Journal of Epidemiology2013